Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, announced inducement equity grants comprising 25,600 share options and 15,000 restricted share units to seven new non-officer employees. These awards, granted at market price and vesting over four years, align with Nasdaq Listing Rule 5635(c)(4) to attract talent. The com…